HBK Investments’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-234
| Closed | -$806K | – | 1236 |
|
|
2018
Q2 | $806K | Buy |
+234
| New | +$806K | 0.01% | 631 |
|
|
2016
Q3 | – | Sell |
-239
| Closed | -$732K | – | 1001 |
|
|
2016
Q2 | $732K | Sell |
239
-110
| -32% | -$337K | 0.01% | 583 |
|
|
2016
Q1 | $1.11M | Buy |
+349
| New | +$1.11M | 0.01% | 505 |
|
|
2015
Q2 | – | Sell |
-95
| Closed | -$380K | – | 1066 |
|
|
2015
Q1 | $380K | Sell |
95
-24
| -20% | -$96K | ﹤0.01% | 728 |
|
|
2014
Q4 | $584K | Buy |
+119
| New | +$584K | 0.01% | 612 |
|
|
2014
Q1 | – | Sell |
-400
| Closed | -$1.4M | – | 1045 |
|
|
2013
Q4 | $1.4M | Buy |
+400
| New | +$1.4M | 0.03% | 343 |
|
|
2013
Q3 | – | Sell |
-68
| Closed | -$267K | – | 955 |
|
|
2013
Q2 | $267K | Buy |
+68
| New | +$267K | ﹤0.01% | 668 |
|